Related Experiment Videos
Task-dependent development of tolerance to scopolamine
Pharmacology, Biochemistry, and Behavior
|August 1, 1980
Summary
Rats developed tolerance to scopolamine's locomotor effects after chronic treatment. However, this tolerance did not impact scopolamine's ability to enhance active avoidance learning in a shuttle box task.
Area of Science:
- Neuroscience
- Pharmacology
- Behavioral Science
Background:
- Scopolamine is a muscarinic receptor antagonist.
- Chronic drug administration can lead to tolerance.
- Task-dependent effects of scopolamine on behavior are not fully understood.
Purpose of the Study:
- To investigate the development of tolerance to scopolamine's effects on locomotor activity and active avoidance learning in rats after chronic treatment.
- To determine if tolerance to scopolamine is task-dependent.
Main Methods:
- Rats received daily injections of scopolamine hydrochloride (0.5 mg/kg) or saline for 21 days.
- Locomotor activity and active avoidance learning in a shuttle box were assessed 48 hours after treatment cessation.
- Acute scopolamine challenge was administered to assess tolerance.
Main Results:
- No significant differences in spontaneous locomotor activity or avoidance learning were observed between groups after chronic treatment.
- Chronic scopolamine treatment led to tolerance in locomotor activity, indicated by a reduced response to acute scopolamine.
- Acute scopolamine equally facilitated active avoidance learning in both chronically treated groups, suggesting no tolerance to this effect.
Conclusions:
- Tolerance to scopolamine's locomotor-stimulatory effects develops with chronic administration.
- Tolerance to scopolamine's effects on active avoidance learning does not appear to develop under these conditions.
- These findings suggest task-dependent development of tolerance to scopolamine's behavioral effects.